Author: Claus Vinther Nielsen
Publisher: Frontiers Media SA
ISBN: 2832510086
Category : Medical
Languages : en
Pages : 104

Get Book Here

Book Description

Author: International Society for Rehabilitation of the Disabled
Publisher:
ISBN:
Category : Rehabilitation
Languages : en
Pages :

Get Book Here

Book Description

Author: International Society for the Welfare of Cripples. World Congress
Publisher:
ISBN:
Category : Rehabilitation
Languages : en
Pages : 0

Get Book Here

Book Description

Author: Rehabilitation International. World Congress
Publisher:
ISBN:
Category : Medical rehabilitation
Languages : en
Pages : 682

Get Book Here

Book Description

Author: International Society for Rehabilitation of the Disabled
Publisher:
ISBN:
Category : Rehabilitation
Languages : en
Pages : 428

Get Book Here

Book Description

Author: Carmen Rodriguez-Blazquez
Publisher: Frontiers Media SA
ISBN: 2889710610
Category : Medical
Languages : en
Pages : 201

Get Book Here

Book Description
Dr. Carmen Rodriguez-Blazquez received support from AbbVie for attending two scientific congresses. Prof. Mayela Rodriguez-Violante received honorariums from Medtronic and Everneuropharma.

Author: Gale Group
Publisher: Gale Cengage
ISBN: 9780787633455
Category : Reference
Languages : en
Pages : 1262

Get Book Here

Book Description
Identifies and describes some 15,000 programs and services available to the general public at little or no cost. These services are provided by federal, state, county and local governments and their agencies as well as by organizations and associations.

Author: Monique Lewis
Publisher: Springer Nature
ISBN: 303079735X
Category : Social Science
Languages : en
Pages : 410

Get Book Here

Book Description
This book explores communication during the first year of the COVID-19 pandemic. Featuring the work of leading communication scholars from around the world, it offers insights and analyses into how individuals, organisations, communities, and nations have grappled with understanding and responding to the pandemic that has rocked the world. The book examines the role of journalists and news media in constructing meanings about the pandemic, with chapters focusing on public interest journalism, health workers and imagined audiences in COVID-19 news. It considers public health responses in different countries, with chapters examining community-driven approaches, communication strategies of governments and political leaders, public health advocacy, and pandemic inequalities. The role of digital media and technology is also unravelled, including social media sharing of misinformation and memetic humour, crowdsourcing initiatives, the use of data in modelling, tracking and tracing, and strategies for managing uncertainties created in a pandemic.

Author: Duo Chen
Publisher: Frontiers Media SA
ISBN: 2832516289
Category : Science
Languages : en
Pages : 209

Get Book Here

Book Description

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483

Get Book Here

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.